Pathological and molecular evaluation of pancreatic neoplasms.
about
Pancreatic cancer: Are "liquid biopsies" ready for prime-time?Pancreatic Cancer, A Mis-interpreter of the Epigenetic LanguageMixed acinar-endocrine carcinoma of pancreas: A case report and brief review of the literature.SEOM Clinical Guideline for the treatment of pancreatic cancer (2016).Roles of autophagy and metabolism in pancreatic cancer cell adaptation to environmental challenges.Overview of pre-clinical and clinical studies targeting angiogenesis in pancreatic ductal adenocarcinoma.Serum C-peptide, Total and High Molecular Weight Adiponectin, and Pancreatic Cancer: Do Associations Differ by Smoking?Preclinical Safety Evaluation in Rats of a Polymeric Matrix Containing an siRNA Drug Used as a Local and Prolonged Delivery System for Pancreatic Cancer Therapy.Current Molecular and Genetic Aspects of Pancreatic Cancer, the Role of Metastasis Associated Proteins (MTA): A Review.Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways.Effect of p53 on pancreatic cancer-glucose tolerance abnormalities by regulating transglutaminase 2 in resistance to glucose metabolic stress.FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis.IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia.Transient and Local Expression of Chemokine and Immune Checkpoint Traps To Treat Pancreatic Cancer.A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancer.Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer.KRAS-related noncoding RNAs in pancreatic ductal adenocarcinoma.Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.Epidemiology and Prospects for Prevention of Pancreatic Cancer 2nd ed
P2860
Q28068665-AB72DC85-77FD-449D-AC8E-96AD1FBD3159Q28079735-06B6E37A-D5A5-4FD8-804B-AECFC4B8E291Q35841550-E4E88397-6E2C-4B57-8070-94B62ABF28F8Q37475173-262F37F5-3321-4CDA-9000-F699666D6854Q38680160-404C2F17-C957-44E4-B922-1EBE3EC22979Q38684978-F89195B6-8313-4813-A680-0EDCBCFDDD4AQ38769343-40F5F652-E56D-4AFD-BE67-6C346A2AE34CQ38871344-593F835A-3F2C-4A55-899E-ACCACF341821Q39070481-B43DD41A-14BF-4FB1-B2A5-378F4745E8A9Q40084337-28A79820-494E-40FF-9634-56203464F732Q46271434-325E5A88-C45F-4137-8AD2-ED34A1614847Q46277412-ABC5E8C3-3895-40A9-B98B-8D2CE50615F3Q47098673-53785B68-9D4B-4DC1-915F-0800E1F92DB0Q47793665-899D30A8-C1B1-48C1-95C3-4B75E6567280Q52597561-B8204094-8B40-48F9-A039-A07DE343E9E5Q52726462-C3041EF1-7879-4790-BBA2-9BD148FD9E20Q53181228-59FAC589-813C-47AA-8553-1D9B6724DB41Q53364786-17B949BD-7961-4F2D-9AF5-86634A36C564Q56779098-737EAEC9-4E76-4A15-AA67-375BE51BFC93
P2860
Pathological and molecular evaluation of pancreatic neoplasms.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Pathological and molecular evaluation of pancreatic neoplasms.
@ast
Pathological and molecular evaluation of pancreatic neoplasms.
@en
type
label
Pathological and molecular evaluation of pancreatic neoplasms.
@ast
Pathological and molecular evaluation of pancreatic neoplasms.
@en
prefLabel
Pathological and molecular evaluation of pancreatic neoplasms.
@ast
Pathological and molecular evaluation of pancreatic neoplasms.
@en
P2860
P1433
P1476
Pathological and molecular evaluation of pancreatic neoplasms.
@en
P2093
Arvind Rishi
Laura D Wood
P2860
P356
10.1053/J.SEMINONCOL.2014.12.004
P577
2014-12-09T00:00:00Z